Remus Pharmaceuticals Limited
- StockSME
- REMUS
- NSE
- ₹901.20−1.59%
- Delayed close, 22 Oct
Details
- INE0O5T01011
- Face value ₹10
- Market cap ₹1,062 Cr
Paid for 4 years without a break
Dividend per share by FY
| Financial year | Total dividend |
|---|---|
| FY24 | ₹0.50 |
| FY25 | ₹1.00 |
| FY26 | ₹1.00 |
| FY27 | ₹0.50 |
TTM payout
₹1.00
2 payouts in 12 months
Yield
0.11%
Dividend yield · trailing 12 months
52-wk closing range ₹582.85 – ₹1,020.75 · split-adjusted
Yield and payout totals recalculated 23 Oct 2026.
Came to market
- Listed
- 29 May 2023
- 3 years 4 months ago
- Issue price
- ₹1,229.00
- SME board
- First dividend
- 3 months
- after listing
Recent payouts
· 7 on record since FY24| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 22 Sep 2026 | Final | same day | ₹0.50 |
| 14 Nov 2025 | Interim | same day | ₹0.50 |
| 18 Sep 2025 | Final | same day | ₹0.50 |
| 19 Nov 2024 | Interim | 20 Nov 2024 | ₹0.50* |
| 02 May 2024 | Interim | same day | ₹0.50* |
Amounts marked * were restated for a later split or bonus so they compare with today’s shares. Switch to “as filed” to see what was actually declared at the time — that is the figure on an old broker statement.
Income calculator
₹110
Expected income per year, before tax, at the current 0.11% yield
≈ 110 shares at ₹901.20, using ₹99,132 of the ₹1,00,000. Based on the last twelve months’ payouts — not a forecast, and dividends are taxed at your own slab rate.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.